ABBV vs AMZN
AbbVie Inc. vs Amazon.com, Inc.
ABBV
AbbVie Inc.
$232.03+3.27%
AMZN
Amazon.com, Inc.
$210.00+1.00%
Key Metrics Comparison
| ABBV | Metric | AMZN |
|---|---|---|
| $232.03 | Price | $210.00 |
| $410.09B | Market Cap | $2.25TBetter |
| 98.74 | P/E Ratio | 29.33Better |
| $2.35 | EPS | $7.16Better |
| +3.27%Better | Day Change | +1.00% |
| $244.81 | 52W High | $258.60 |
| $164.39 | 52W Low | $161.38 |
| 4,213,578 | Volume | 43,398,432Better |
| 6,401,624 | Avg Volume | 47,532,393Better |
About AbbVie Inc.
Healthcare | Drug Manufacturers - General
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for th...
About Amazon.com, Inc.
Consumer Cyclical | Specialty Retail
Amazon.com, Inc. engages in the retail sale of consumer products and subscriptions through online and physical stores in North America and internationally. The company operates through three segments: North America, International, and Amazon Web Services (AWS). Its products offered through its store...